Author

Brett J. Skinner

Observed names: B. J. SKINNER, Brett J Skinner, Brett Skinner

ORCID: 0000-0002-5092-9833

Observed ORCID: 0000-0002-5092-9833

OpenAlex ID: A5050490402

Waiting Your Turn: Wait Times for Health Care in Canada 2010 Report

2011 · Bacchus Barua, Mark C. Rovere, et al. · SSRN Electronic Journal · 139

Price Controls, Patents, and Cross-Border Internet Pharmacies Risks to Canada's Drug Supply and International Trading Relations

2006 · Brett J. Skinner · 11

Canada's Medicare Bubble: Is Government Health Spending Sustainable without User-Based Funding?

2011 · Mark C. Rovere, Brett J. Skinner · SSRN Electronic Journal · 10

Increased health costs from mandated Therapeutic Substitution of proton pump inhibitors in British Columbia

2009 · B. J. SKINNER, J. R. GRAY, et al. · Alimentary Pharmacology & Therapeutics · 9

Waiting for Reimbursement of New Medicines in Canada

2008 · Brett J Skinner · PharmacoEconomics · 7

New cancer drugs in Canada 2012 to 2021: an economic analysis of cost, benefit, availability, and public insurance coverage.

2023 · Brett J Skinner · Canadian Health Policy · 6

PDF

Canada's Drug Price Paradox 2007

2007 · Brett J. Skinner, Mark C. Rovere · 5

Access Delayed, Access Denied: Waiting for New Medicines in Canada: 2010 Report

2011 · Brett J. Skinner, Mark C. Rovere · SSRN Electronic Journal · 4

Medicare, the Medical Brain Drain and Human Resource Shortages in Health Care

2002 · Brett J. Skinner · 4

Access Delayed, Access Denied 2012: Waiting for New Medicines in Canada

2011 · Mark C. Rovere, Brett J. Skinner · SSRN Electronic Journal · 3

Access Delayed, Access Denied Waiting for New Medicines in Canada 2011 Report

2011 · Mark C. Rovere, Brett J. Skinner · 2

Government development of ‘made-in-Canada’ CAR-T cell immunotherapies: assessing cost, risk, access, and alternatives

2024 · Brett J Skinner · Canadian Health Policy · 1

PDF

Public v private insurance coverage for new drugs in Canada, 2018-2023, 7th EditionPublic v private insurance coverage for new drugs in Canada, 2018-2023, 7th Edition

2024 · Brett Skinner · Canadian Health Policy · 1

PDF

Access to new medicines in Canada 2016-2021 Federal-provincial public drug programs and private sector drug plans

2022 · Mark Rovere, Brett Skinner · Canadian Health Policy · 1

Pharmacy scope of practice and access to Opioid Agonist Therapies (OAT) in Canada after COVID-19

2022 · Sarah Lussier-Hoskyn, Brett Skinner · Canadian Health Policy · 1

PDF

Economic cost of cardiomyopathy in Canada 2018 to 2021: opportunity for cost avoidance through pharmaceutical innovation.

2023 · Brett J Skinner · Canadian Health Policy

PDF

The Misguided War against Medicines 2011

2011 · Brett J. Skinner, Mark C. Rovere · SSRN Electronic Journal

Realities of Health Policy in North America: Government Is the Problem, Not the Solution

2008 · Brett J. Skinner · Economic Affairs

The Benefits of Allowing Business Back Into Canadian Health Care

2002 · Brett J. Skinner

The medical brain drain and its potential to affect health care in Canada.

2001 · Brett J. Skinner · Scholarship at UWindsor (University of Windsor)

Works count: 20

Citation count: 204

H-index: 6

I10-index: 3